Prothena Corp Public Ltd Co (PRTA) stock
PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3022% below fair value
$8.35+0.09 (+1.09%)
Close on Nov 18, 2026Market cap $428.66MP/E –Yield –
Prothena Corp Public pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Prothena Corp Public's pe ratio was 23.9× on Jul 29, 2022.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jul 29, 2022 | 23.9× | −24.1 |
| 2021 | Dec 31, 2021 | 48.0× | – |
See a number that looks wrong?